During the past decade, University at Buffalo conducted 142 clinical trials. In the 10-year time frame, 142 clinical trials started and 56 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 40 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University at Buffalo" #1 sponsor was "State University of New York at Buffalo" with 57 trials, followed by "University at Buffalo" with 9 trials sponsored, "Edwards Lifesciences" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 120 different institutions and companies that sponsored additional 105 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University at Buffalo" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 11 trials as a collaborator, "University at Buffalo" with 8 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 6 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator and "National Center for Advancing Translational Sciences (NCATS)" with 4 trials as a collaborator. Other collaborators include 119 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "University at Buffalo" are "Obesity" (9 trials), "Ischemic Stroke" (6 trials), "COVID-19" (4 trials), "Fatigue" (4 trials) and "Intracerebral Hemorrhage" (4 trials). Many other conditions were trialed in "University at Buffalo" in a lesser frequency.

Most popular intervention types in "University at Buffalo" are "Drug" (69 trials), "Device" (54 trials), "Behavioral" (36 trials), "Other" (35 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "BMS-986036" (2 trials), "Edwards PASCAL System" (2 trials), "Esketamine" (2 trials) and "Gabapentin" (2 trials). Other intervention names were less common.

The vast majority of trials in "University at Buffalo" are 186 trials for "All" genders, 17 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 69 active trials in "University at Buffalo". 2 are not yet recruiting, 39 are recruiting, 23 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 117 completed trials in University at Buffalo, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in University at Buffalo, 5 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 100 trials that are defined as “Not Applicable".

University at Buffalo has several departments that took part in Clinical trials: "SUNY - Buffalo, Erie County Medical Ctr." - 46 trials, "University at Buffalo Division of Behavioral Medicine" - 15 trials, "School of Dental Medicine" - 10 trials, "University at Buffalo/Buffalo General Medical Center" - 6 trials, "The Cystic Fibrosis Center of Western New York" - 4 trials, "Diabetes Endocrinology Research Center of WNY" - 4 trials, "University at Buffalo Department of Psychology" - 3 trials, "Department of Periodontics and Endodontics,School of Dental Medicine, University at Buffalo, SUNY" - 2 trials, "Alzheimer's Disease and Memory Disorders Center" - 2 trials